Significance of white-coat and masked hypertension in chronic kidney disease and end-stage renal disease.

Posted at — Mario Hernández Cueto — octubre 31st, 2014 — 9:12 under Revisiones

Significance of white-coat and masked hypertension in chronic kidney disease and end-stage renal disease.

Revisiones sistematicas.Por: José Boggia, Ricardo Silvariño, Leonella Luzardo y Oscar Noboa.   Hypertension Research (2014) 37, 882–889.

Hypertension is a frequent and modifiable cardiovascular risk factor with a cyclic relationship with chronic kidney disease (CKD). The diagnosis, treatment, monitoring and control of high blood pressure are all mandatory not only in CKD but also in end-stage renal disease (ESRD). As demonstrated by studies using population and hypertensive patients, white-coat hypertension (WCHT) and masked hypertension (MHT) carry a particular degree of risk. The advantages of ambulatory techniques in the management and prognostic stratification of patients with CKD and ESRD have also been recognized.

No responses yet